Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : QLT PhotoTherapeutics (QLTI) -- Ignore unavailable to you. Want to Upgrade?

To: Ian@SI who wrote (855)	3/26/2000 1:39:00 PM
From: Julian	Read Replies (1) \| Respond to of 1321

Zacks research on QLTI as of March 24, 2000 # of brokers ... ........... Months Ago recommending as: ..... 0.......1.......2.......3 strong buy ... ............ 9.......9.......9.......9 moderate buy .. ........ 0.......0.......0.......0 hold .. .. ................... 1.......2.......2.......2 moderate sell.. .......... 0.......0.......0.......0 strong sell ... ............. 1.......1.......1.......1 ............................. .. _......._........_......._.. mean * .. .............. 1.55.. 1.67.. 1.67.. 1.67 * (strong buy) 1.00 - 5.00 (strong sell) Covering Brokers Adams Harkness and Hill Inc., CIBC World Markets, Credit Suisse First Boston Corp., Deutsche Bank Securities,Dundee Securities, ING Baring Furman Selz LLC., Leerink Swann and Co., Merrill Lynch and Co., National Bank Financial, Scotia Capital Markets, Warburg Dillon Reed, Yorkton Seccurities Inc. HCFP/Brenner Securities removed from list. National Bank Financial ADDED to list.